COROPREDICT

EUIPO EUIPO 2014 Trademark registered

The displayed mark can be extended.
Click here, to extend trademark protection for a further 10 years.

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark COROPREDICT was filed as Word mark on 09/02/2014 at the European Union Intellectual Property Office.
It was registered as a trademark on 01/23/2015. The current status of the mark is "Trademark registered".

Extend brand

Trademark Details Last update: October 15, 2024

Trademark form Word mark
File reference 013221452
Application date September 2, 2014
Publication date October 16, 2014
Entry date January 23, 2015
Expiration date September 2, 2024

Trademark owner

Im Brambusch 21
69493 Hirschberg
DE
Backgasse 4
69412 Eberbach
DE

Trademark representatives

Lehel Carré Gewürzmühlstrasse 11 80538 München DE

goods and services

5 Pharmaceutical and veterinary preparations for medical or veterinary purposes, in particular for prevention; Diagnosis and/or treatment of cardiovascular diseases, in particular in the field of personalised medicine relating to the customised diagnosis and treatment of an individual, including medical tests, in particular for evaluation; Analysis and/or assessment of the risk relating to the occurrence of a disease, the progression of the disease and the mortality risk, in particular establishing of clinical parameters and/or physiological biomarkers which influence the evaluation, analysis or risk assessment in question, in particular for clinical and media applications in the field of coronary heart disease, including heart failure, renal failure and diabetes mellitus, in particular through correlation of clinical parameters and/or physiological biomarkers based on algorithms; Preparations for diagnostic and/or therapeutic purposes, in particular for assisting specialist medical and clinical personnel to make decisions relating to the selection of preventive, diagnostic and/or treatment measures; Dietary supplements for humans and animals
42 Scientific and technological services and research services, In particular providing and analysis of patient data for scientific, analytical and/or clinical purposes, In particular analysis and Assessment of patient-oriented clinical, biochemical, molecular and/or genomic parameters and data, including statistical evaluations and risk calculations on the basis of cohort studies, in particular analysis of clinical, physiological and/or molecular biomarkers which are connected to the occurrence and progression of coronary heart disease; Design relating thereto in the form of compilation, providing and mathematical correlation of medical information obtained through analysis and evaluation of clinical, biochemical and/or genetic information from individual patients and patient groups; Industrial analysis and research services for basic scientific research and for analytical purposes in the context of clinical studies, in particular compilation of mathematical, statistical data and clinical data in relation to individual patient groups; Design and development of computer hardware and software in relation thereto, in particular computer software for use by medical specialists for clinical diagnostics and treatment of individual patients, in particular in the field of cardiovascular disease; Providing of software for optimising diagnosis and treatment by obtaining and correlating clinical parameters and molecular biomarkers, in particular through mathematical correlation on the basis of algorithms, in particular in the form of downloadable computer software for use on mobile apparatus, in particular smartphones and tablets
44 Medical services, In particular in the form of issuing of medical and scientific information and scientific consultancy in the field of personalised medicine, in particular in the field of diagnosis and treatment of cardiovascular diseases; Medical consultancy relating to the use of medicines and the interpretation of clinical studies and clinical parameters with regard to individual medical treatment methods for individual patients, in particular in the field of clinical prevention, diagnostics and treatment; Medical services by means of providing an information platform featuring doctors and specialist medical personnel; Treatment methods in the context of personalised medicine, in particular in the field of cardiovascular diseases, in particular optimising the course of a disease through risk assessment in clinical practice

Trademark history

Date Document number Area Entry
September 18, 2024 Change Representative, Published
February 5, 2024 Extension, Notification of expiry of trade mark
February 21, 2022 Change Representative, Published
January 16, 2019 Change Representative, Published
January 16, 2019 Change Representative, Published
September 8, 2014 Transfer / Change of address, Registered

ID: 11013221452